Financial Enhancement Group LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1641438 ANDERSON, IN

Position in ARWR

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$448,305

+$103,455 QoQ

Shares Held

5,500

0.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

#304

of 497 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Financial Enhancement Group LLC holds $2,033,789 across 3 Biotechnology names. ARWR ranks #2 (22.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TRAX	First Tracks Biotherapeutics, Inc.	74,450	$1,497,934
2	ARWR	Arrowhead Pharmaceuticals, Inc. This page	5,500	$448,305
3	IBRX	ImmunityBio, Inc.	10,000	$87,550

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$448,305	5,500	0.0%	Shares	Sole	2026-07-07
2026-03-31	$344,850	5,500	-0.5%	Shares	Sole	2026-04-20
2025-12-31	$366,804	5,525	—	Shares	Sole	2026-01-23
No filing history on record for this holder in this stock.